Intra-Cellular Therapies

Intra-Cellular Therapies

Intra-Cellular Therapies

Type
B2c
Founded
2002
Raised
$210M
Follow us
Alexa global traffic share
Latest funding
$150,000,000
Post-IPO equity - 2017
$60,000,000
Secondary market - 2013
Team Size
10+
Employees
The Motley Fool

Why Intra-Cellular Therapies Inc Stock Jump 21.4% in April

The Motley Fool

Why Intra-Cellular Therapies Inc. Stock Rocketed 206% Higher In 2015 --

Stock markets Health